×
Artivion Net Cash Flow 2010-2025 | AORT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Artivion net cash flow from 2010 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.
View More
Artivion Net Cash Flow 2010-2025 | AORT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Artivion net cash flow from 2010 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$186.1B
Intuitive Surgical (ISRG)
$169.7B
IDEXX Laboratories (IDXX)
$51.8B
Edwards Lifesciences (EW)
$47.8B
Alcon (ALC)
$39.4B
IQVIA Holdings (IQV)
$32.4B
DexCom (DXCM)
$29.5B
Mettler-Toledo (MTD)
$26.8B
STERIS (STE)
$24.1B
Waters (WAT)
$18B
SONOVA HOLDING (SONVY)
$17.4B
Hologic (HOLX)
$14.9B
Penumbra (PEN)
$10.6B
Globus Medical (GMED)
$8.3B
Sysmex ADR (SSMXY)
$7.9B
Masimo (MASI)
$7.6B
Teleflex (TFX)
$5.6B
Glaukos (GKOS)
$5.5B
TransMedics (TMDX)
$3.9B
Integer Holdings (ITGR)
$3.8B
LivaNova (LIVN)
$3.1B
Veracyte (VCYT)
$2.4B
Alphatec Holdings (ATEC)
$2.4B
PROCEPT BioRobotics (PRCT)
$2.2B
Nihon Kohden (NHNKY)
$2B
Elekta AB (EKTAY)
$1.8B
Integra LifeSciences Holdings (IART)
$1.2B
Paragon 28 (FNA)
$1.1B
OPKO Health (OPK)
$1.1B
Pulse Biosciences (PLSE)
$1B